Edgewise Total Assets from 2010 to 2024

EWTX Stock

USD 31.98 0.22 0.68%

Edgewise Therapeutics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 252.6 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

340 M

Current Value

252.6 M

Quarterly Volatility

131.9 M

Credit Downgrade

Yuan Drop

Covid

Check Edgewise Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Edgewise Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 14.9 M, Interest Income of 14.9 M or Depreciation And Amortization of 1.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.3. Edgewise financial statements analysis is a perfect complement when working with Edgewise Therapeutics Valuation or Volatility modules.

Check out the analysis of Edgewise Therapeutics Correlation against competitors.

For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.

Latest Edgewise Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Edgewise Therapeutics over the last few years. Total assets refers to the total amount of Edgewise Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Edgewise Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Edgewise Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Edgewise Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 340.04 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Edgewise Total Assets Regression Statistics

	Arithmetic Mean	108,099,008
	Geometric Mean	53,872,735
	Coefficient Of Variation	121.99
	Mean Deviation	111,410,677
	Median	24,541,000
	Standard Deviation	131,875,157
	Sample Variance	17391.1T
	Range	342.6M
	R-Value	0.80
	Mean Square Error	6890.1T
	R-Squared	0.63
	Significance	0.0004
	Slope	23,444,717
	Total Sum of Squares	243474.8T

Edgewise Total Assets History

	2024	252.6 M
	2023	340 M
	2022	367.1 M
	2021	285.2 M
	2020	131.1 M

Other Fundumenentals of Edgewise Therapeutics

Intangibles To Total Assets

Edgewise Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Property Plant Equipment	Deferred Long Term Liab	Net Receivables	Capital Surpluse	Common Stock	Short Term Debt
Total Assets		0.97	0.94	-0.84	-0.86	0.98	-0.2	0.97	1.0	1.0	0.83	-0.97	-0.84	0.82	0.78	0.59
Total Stockholder Equity	0.97		0.95	-0.89	-0.84	0.97	-0.43	1.0	0.97	0.97	0.82	-0.99	-0.84	0.82	0.77	0.58
Net Tangible Assets	0.94	0.95		-0.76	-0.95	0.92	-0.38	0.95	0.94	0.94	0.92	-0.96	-0.88	0.86	0.88	0.74
Net Debt	-0.84	-0.89	-0.76		0.54	-0.9	0.46	-0.89	-0.84	-0.84	-0.55	0.87	0.59	-0.52	-0.43	-0.15
Retained Earnings	-0.86	-0.84	-0.95	0.54		-0.81	0.24	-0.84	-0.86	-0.86	-0.97	0.85	0.93	-0.93	-0.98	-0.89
Accounts Payable	0.98	0.97	0.92	-0.9	-0.81		-0.26	0.97	0.98	0.98	0.82	-0.95	-0.84	0.79	0.73	0.48
Total Liab	-0.2	-0.43	-0.38	0.46	0.24	-0.26		-0.43	-0.19	-0.19	-0.25	0.41	0.27	-0.27	-0.24	-0.18
Net Invested Capital	0.97	1.0	0.95	-0.89	-0.84	0.97	-0.43		0.97	0.97	0.82	-0.99	-0.84	0.82	0.77	0.58
Total Current Assets	1.0	0.97	0.94	-0.84	-0.86	0.98	-0.19	0.97		1.0	0.82	-0.97	-0.84	0.81	0.77	0.59
Net Working Capital	1.0	0.97	0.94	-0.84	-0.86	0.98	-0.19	0.97	1.0		0.82	-0.97	-0.83	0.81	0.77	0.58
Property Plant Equipment	0.83	0.82	0.92	-0.55	-0.97	0.82	-0.25	0.82	0.82	0.82		-0.8	-0.98	0.95	0.97	0.82
Deferred Long Term Liab	-0.97	-0.99	-0.96	0.87	0.85	-0.95	0.41	-0.99	-0.97	-0.97	-0.8		0.81	-0.8	-0.76	-0.6
Net Receivables	-0.84	-0.84	-0.88	0.59	0.93	-0.84	0.27	-0.84	-0.84	-0.83	-0.98	0.81		-0.98	-0.95	-0.76
Capital Surpluse	0.82	0.82	0.86	-0.52	-0.93	0.79	-0.27	0.82	0.81	0.81	0.95	-0.8	-0.98		0.97	0.83
Common Stock	0.78	0.77	0.88	-0.43	-0.98	0.73	-0.24	0.77	0.77	0.77	0.97	-0.76	-0.95	0.97		0.92
Short Term Debt	0.59	0.58	0.74	-0.15	-0.89	0.48	-0.18	0.58	0.59	0.58	0.82	-0.6	-0.76	0.83	0.92

Click cells to compare fundamentals

About Edgewise Therapeutics Financial Statements

Edgewise Therapeutics investors use historical fundamental indicators, such as Edgewise Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Edgewise Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	340 M	252.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Edgewise Stock Analysis

When running Edgewise Therapeutics' price analysis, check to measure Edgewise Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edgewise Therapeutics is operating at the current time. Most of Edgewise Therapeutics' value examination focuses on studying past and present price action to predict the probability of Edgewise Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edgewise Therapeutics' price. Additionally, you may evaluate how the addition of Edgewise Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC